Resveratrol upregulates cardiac SDF-1 in mice with acute myocardial infarction through the deacetylation of cardiac p53

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Hong, Wang ^a   Tatsuo, Shimosawa ^b   Shou Dong, Wang ^c   Qian, Zhang ^d   Jian Feng, Hou ^d   Jue, Wang ^d   Chen, Jin ^d   Hai Yan, Qian ^d   Yue Jin, Yang ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; PROTEIN P53; RESVERATROL; SIRTUIN 1; STROMAL CELL DERIVED FACTOR 1; STILBENE DERIVATIVE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART RATE; IN VITRO STUDY; INTERVENTRICULAR SEPTAL DIMENSION; INTRACELLULAR SIGNALING; LEFT VENTRICULAR END DIASTOLIC DIMENSION; LEFT VENTRICULAR END SYSTOLIC DIMENSION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL MOBILIZATION; UPREGULATION; ACETYLATION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL HYPOXIA; DIAGNOSTIC IMAGING; DRUG EFFECTS; ECHOGRAPHY; FIBROSIS; GENE SILENCING; HEART FUNCTION TEST; HEART INFARCTION; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS; RICE STRIPE VIRUS;

ACETYLATION; ANIMALS; CELL HYPOXIA; CHEMOKINE CXCL12; FIBROSIS; GENE SILENCING; HEART FUNCTION TESTS; HEART VENTRICLES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; SIRTUIN 1; STILBENES; TUMOR SUPPRESSOR PROTEIN P53; ULTRASONOGRAPHY; UP-REGULATION;

EID: 84936806647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128978     Document Type: Article

References (30)

1. Singh S, Arora R, Handa K, Khraisat A, Nagajothi N, Molnar J, et al. Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol. 2009; 32:176-180. doi: 10.1002/clc.20470 PMID: 19353705
2. Mohsin S, Siddiqi S, Collins B, Sussman MA. Empowering adult stem cells for myocardial regeneration. Circ Res. 2011; 109:1415-1428. doi: 10.1161/CIRCRESAHA.111.243071 PMID: 22158649
3. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther. 2011; 129:97-108. doi: 10.1016/j.pharmthera.2010.09.011 PMID: 20965212
4. Penn MS, Pastore J, Miller T, Aras R. SDF-1 in myocardial repair. Gene Ther. 2012; 19:583-587. doi: 10.1038/gt.2012.32 PMID: 22673496
5. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004; 110:3300-3305. PMID: 15533866
6. Wang Y, Haider HKH, Ahmad N, Zhang D, Ashraf M. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol. 2006; 41:478-487. PMID: 16926022
7. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation. 2007; 116:1683-1692. PMID: 17875967
8. Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013; 112:816-825. doi: 10.1161/CIRCRESAHA.111.300440 PMID: 23429605
9. Wang H, Yang YJ, Qian HY, Zhang Q, Xu H, Li JJ. Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev. 2012; 17:437-448. doi: 10.1007/s10741-011-9260-4 PMID: 21688187
10. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 2005; 280:17187-17195. PMID: 15749705
11. Borradaile NM, Pickering JG. NAD+, Sirtuins, and Cardiovascular Disease. Curr Pharm Des. 2009; 15:110-117. PMID: 19149606
12. Nguyen PD, Tutela JP, Thanik VD, Knobel D, Allen RJ Jr., Chang CC, et al. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Repair Regen. 2010; 18:553-559. doi: 10.1111/j.1524-475X.2010.00638.x PMID: 20955346
13. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res. 2006; 12:10671-10676.
14. Addadi Y, Moskovits N, Granot D, Lozano G, Carmi Y, Apte RN, et al. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. Cancer Res. 2010; 70:9650-9658. doi: 10.1158/0008-5472.CAN-10-1146 PMID: 20952507
15. Wang H, Yang YJ, Qian HY, Zhang Q, Gao LJ, Li P, et al. Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction. Physiol Res. 2012; 61:543-549. PMID: 23240923
16. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010; 8:e1000412. doi: 10.1371/journal.pbio.1000412 PMID: 20613859
17. Anderson GD, Peterson TC, Farin FM, Bammler TK, Beyer RP, Kantor ED, et al. The effect of nicotinamide on gene expression in a traumatic brain injury model. Front Neurosci. 2013; 7:21. doi: 10.3389/fnins.2013.00021 PMID: 23550224
18. Xu W, Lu Y, Yao J, Li Z, Chen Z, Wang G, et al. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury. Shock. 2014; 42:440-447. doi: 10.1097/SHK.0000000000000225 PMID: 25004063
19. Jian B, Yang S, Chaudry IH, Raju R. Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol Med. 2012; 18:209-214. doi: 10.2119/molmed.2011.00365 PMID: 22113495
20. Samuel SM, Thirunavukkarasu M, Penumathsa SV, Paul D, Maulik N. Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. J Agric Food Chem. 2008; 56:9692-9698. doi: 10.1021/jf802050h PMID: 18826227
21. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, et al. Silent information regulator1 protects the heart from ischemia/reperfusion. Circulation. 2010; 122:2170-2182. doi: 10.1161/CIRCULATIONAHA.110.958033 PMID: 21060073
22. Nadtochiy SM, Redman E, Rahman I, Brookes PS. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res. 2011; 89:643-649. doi: 10.1093/cvr/cvq287 PMID: 20823277
23. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res. 2004; 95:971-980. PMID: 15486319
24. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001; 107:149-159. PMID: 11672523
25. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, et al. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 2001; 20:1331-1440. PMID: 11250899
26. Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, et al. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol. 2006; 26:2782-2790. PMID: 16537920
27. Olive M, Mellad JA, Beltran LE, Ma M, Cimato T, Noguchi AC, et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. J Clin Invest. 2008; 118:2050-2061. doi: 10.1172/JCI31244 PMID: 18464929
28. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.Proc Natl Acad Sci U S A. 2003; 100:10794-10799. PMID: 12960381
29. Tang J, Wang J, Song H, Huang Y, Yang J, Kong X, et al. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep. 2010; 37:1957-1969. doi: 10.1007/s11033-009-9642-z PMID: 19653123
30. Wei SG, Zhang ZH, Yu Y, Weiss RM, Felder RB. Central actions of the chemokine stromal cell-derived factor 1 contribute to neurohumoral excitation in heart failure rats. Hypertension. 2012; 59:991-998. doi: 10.1161/HYPERTENSIONAHA.111.188086 PMID: 22493069